Bill Title: A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced) 2024-12-09 - Read twice and referred to the Committee on Finance. [SB5459 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
No bill text drafts for US Congress SB5459 currently on file.

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for US Congress SB5459

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for US Congress SB5459 currently on file.

Social Comments on US SB5459